OxiSelect™ Cellular UV-Induced DNA Damage ELISA test kit (CPD)

Order OxiSelect Cellular UV-Induced DNA Damage ELISA test kit CPD 01010899796 at Gentaur OxiSelect™ Cellular UV DNA Damage kit (CPD)

Contact

OxiSelect™ Cellular UV-Induced DNA Damage ELISA test kit (CPD)

Size

96 assays

Catalog no.

STA-326

Price

694 EUR

 

Details

The temperatureerature for storage is

4ºC

This reagent is purified

0.97

Species compatible to

Humans

Tissue

cellular

Use of this test kit or product

Genetics lab

Living modified organisme in this reagent or LMO

Not applicable

We send this reagant on

Room temperature

Molecular weight

in kilo Danlto or kDa

Type of reagent

Oxidative Stress/Damage

Antigen

a specific protein sequence

Group

Enzyme-Linked Immunosorbent Assay kits

Cellular use

Measure CPD structures of DNA lesions induced by UV light

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Protocol information

Intact cells are cultured in a 96-well plate and CPD measured by ELISA

Buffer

The concentration in mg/ml in a 10mM of buffered solution at pH 7 to 7,64

Related techniques

Oxidative Stress/ Damage, DNA / RNA Damage and Repair, UV Induced DNA Damage test kits

SDS or safty data sheet

(STA-326) GHS.pdf

Technical file

kit.pdf

Description

Induced protein genes, factors or kinases, increase the production of (an enzyme or other protein) at the level of genetic transcription.

Storage

Human ELISAs or ELISA kits will be stored at +4°C. The expiry date is mostly determined by the standard stability. If your ELISA kit is expired we can supply a new standard so it will still be functional.

Use of the reagent

Our OxiSelect™ Cellular UV-Induced DNA Damage ELISA test kit mesaures the formation of cyclobutane pyrimidine dimers (CPD) in intact cells. Cells are first seeded in a 96-well tissue culture plate. Wells are then UV irradiated to induce DNA damage. After fixation and denaturation, cells containing the DNA lesions are probed with an anti-CPD antibody, followed by an HRP conjugated secondary antibody.